nattiyap@gmail.com – Page 23 – Asian Pacific Journal of Allergy and Immunology

March 16, 2020

Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians

Omalizumab has > 15 years of real-world evidence of effectiveness in Caucasian patients. In August 2017, it was approved as an add-on therapy for the management of moderate-to-severe asthma in China.

Asthma, Caucasian, Chinese, comparative analysis, Omalizumab

March 9, 2020

Serologic status and vaccine response against hepatitis B virus after allogeneic hematopoietic cell transplantation in pediatric patients

Although vaccination against hepatitis B virus (HBV) is recommended for hematopoietic cell transplantation (HCT) recipients, previous studies evaluating serologic status and immunologic response to HBV vaccination in pediatric allogeneic HCT recipients are not enough.

child, hepatitis B virus, leukemia, stem cell transplantation, vaccination

March 9, 2020

Effect of moderate to severe atopic dermatitis on the prognosis of egg allergy resolution

Few studies have examined the effect of atopic dermatitis (AD) on the resolution of food allergies in Asia, and the predictors of egg allergy resolution are not yet well defined.

atopic dermatitis, child, Egg allergy, food allergy, prognosis

February 14, 2020

Corticosteroid-induced drug reaction with eosinophilia and systematic symptoms successfully treated with a tumor necrosis factor alpha inhibitor

Despite recent advances in the treatment of drug reaction with eosinophilia and systemic symptoms (DRESS), the mainstay of treatment involves discontinuing the culprit drugs and administering topical or systemic corticosteroid.

Drug Eruption, Drug Hypersensitivity Syndrome, Etanercept, Steroids, Tumor Necrosis Factor-alpha

February 14, 2020

An unequal endotoxin distribution in typical house types of Ho Chi Minh city

Endotoxin exposure may cause asthma exacerbations and contribute to non-atopic respiratory diseases. Viet Nam, a country with multiple house types, is lacking data on indoor contamination by endotoxin in regard with house types.

Endotoxin, explanatory factors, house dust, house types, room types

February 14, 2020

Determination of specific autoantibodies in patients with systemic lupus erythematosus by Line immunoassay, ELISA and CLIF

Detection of specific antinuclear antibodies (ANA) is very importance in term of diagnosis, prognosis and management of patients with systemic lupus erythematosus (SLE). To date, Line immunoassay (LIA), enzyme-linked immunosorbent assay (ELISA) and Crithidia luciliae indirect immunofluorescence assay (CLIF) are commonly used for detection of specific ANA.

Crithidia luciliae indirect immunofluorescence assay (CLIF), Enzyme-linked immunosorbent assay (ELISA), Line immunoassay (LIA), Specific antinuclear antibodies, Systemic lupus erythematosus (SLE)

January 29, 2020

Enzyme replacement therapy desensitization in a child with infantile onset Pompe disease

Enzyme replacement therapy significantly reduces morbidity and mortality in patients with Pompe disease. Development of hypersensitivity reactions to enzyme replacement therapy is common and can adversely affect disease outcomes when treatment is halted or delayed.

alglucosidase alfa, Desensitisation, Enzyme replacement, hypersensitivity, Pompe disease

January 20, 2020

Clinical characteristics and outcomes of ocular allergy in Thai children

Allergic conjunctivitis (AC) is the most common ocular condition in allergic children. In tropical countries, the study about the clinical features and outcome of treatment is very limited.

allergic conjunctivitis, conjunctivitis, keratoconjunctivitis, Tacrolimus, Treatment outcome

January 6, 2020

Incidence and predictors of nevirapine and efavirenz-associated rash among Indonesian HIV patients

Many drugs used for the treatment of HIV disease can cause drug hypersensitivity reactions. Since 2002, World Health Organization (WHO) has recommended the use of nevirapine and efavirenz as part of first line antiretroviral therapies for several years. Both of the drugs had equivalent clinical efficacy but differences in toxicity profile.

efavirenz, HIV, nevirapine, Predictor, rash

January 2, 2020

Risk factors of uncontrolled symptoms using the standard dose of second-generation H1 -antihistamines in chronic spontaneous urticaria children

A standard dose of second-generation H1 -antihistamines is recommended as the first-line treatment of chronic spontaneous urticaria (CSU), previous studies have found that approximately 20-50% of CSU children fail to control their symptoms and required step-up treatments.

child, chronic spontaneous urticaria, risk factor, second-generation H1 -antihistamines, uncontrolled symptoms